“The exception for one girl and boring surgical procedure (ssp)” in 21 cfr 1271.15(b) states that which is not necessary observe the rules set forth in part 1271 21 cfr, if institution selects and injects hct/p autologously, in the mode of {the same surgical {work|procedure|actions} and {during|during} {volume|their} original form ({if|if} {they|are} processed, {allowed|out} {only|only} washing, cleaning, calibration and shaping) (227, 228). in {otherwise|other situation|other case}, the algorithm {gets|departs|proceeds to} the requirements of 21 cfr 1271.10(a). The criteria given {in this section|here|here} indicate {the|fact|nuance} that hct/p is subjected to minimal manipulation; {intended for|focused on} homologous {work|application| use} is not combined with {surrounding|other} {active substances|active substances}; does not {have | has} a systemic {effectiveness |action | effect} and {in case | when} a systemic effect occurs, it is administered autologously or to blood relatives of the first /second degree of kinship (227). if {these|such|similar|data} criteria are met, the FDA {implies|authorizes} the use of cellular {treatment|therapy} within the {rates|limits} of regulatory guidelines governing the transmission of {diseases|pathologies}, {but|however} without prior approval {on the market|in the field of trade}/submitting {an application|application} for {licensing|obtaining a license} for biologics, exclusively {in accordance with|under|respectively|in accordance with} section 361 of the Public Health Service Act (PHS) and {requirements|provisions} 21 CFR, Part 1271. {otherwise|otherwise|in a different way|in a different way}, if a cell therapy {contradicts|does not meet} the criteria {set forth|set forth in|listed in} 21 cfr 1271.10(a), it is regulated as a biological product {according to|in accordance with|according to} The Federal Law on {Products|Foodstuffs|Foodstuffs}, Medicines, https://autismrecoveryclinic.com/ and Cosmetology (fd